Ivonescimab Antibody

SKU: orb1980401

Description

Ivonescimab (AK112) is a bispecific antibody targeting both PD-1 and VEGF, designed for cancer immunotherapy and anti-angiogenic therapy in NSCLC. It is utilized in preclinical research to investigate its mechanisms and efficacy in both in vitro cellular assays and in vivo tumor models.

Research Area

Cardiovascular Research, Cell Biology, Immunology & Inflammation, Signal Transduction

Images & Validation

−

Key Properties

−

Antibody Type	Inhibitor Antibody
Clonality	Recombinant
Target	PD-1/PD-L1,VEGFR
Molecular Weight	201.12 kDa
Purity	>95.0% (May vary between batches)
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Concentration	9.55 mg/mL
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

AK 112, AK112, SMT112, SMT-112

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

PD-1/PD-L1,VEGFR

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols